Incyte (INCY) Revenue (2010 - 2026)
Incyte (INCY) reported Revenue of $1.3 billion for Q1 2026, up 20.87% on a YoY basis from $1.1 billion in Q1 2025, and down 15.54% quarter-over-quarter from $1.5 billion in Q4 2025.
Incyte (INCY) Revenue (2010 - 2026) Analysis & Trends
Incyte has reported Revenue for 17 years, with the latest figure at $1.3 billion in Q1 2026.
- For the quarter ending Q1 2026, Revenue rose 20.87% year-over-year to $1.3 billion; the trailing twelve-month figure through Mar 2026 stood at $5.4 billion (up 21.48% YoY), and the FY2025 full-year result was $5.1 billion, up 21.22% from the prior year.
- Revenue for Q1 2026 stood at $1.3 billion, down from $1.5 billion in the prior quarter.
- The five-year high for Revenue was $1.5 billion in Q4 2025, with the low at $733.2 million in Q1 2022.
- Historically, Revenue has averaged $1.0 billion across 5 years, with a median of $1.0 billion in 2023.
- The largest YoY upside for Revenue was 29.15% in 2022 against a maximum downside of 1.27% in 2022.
- Incyte's Revenue stood at $926.7 million in 2022, then grew by 9.35% to $1.0 billion in 2023, then climbed by 16.32% to $1.2 billion in 2024, then grew by 27.84% to $1.5 billion in 2025, then decreased by 15.54% to $1.3 billion in 2026.
- The last three Revenue figures came in at $1.3 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.4 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Incyte | 19.62 Bn | 15.60 Bn | 1.17 Bn | 1.27 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.27 Bn |
| Dec 31, 2025 | 1.51 Bn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.22 Bn |
| Mar 31, 2025 | 1.05 Bn |
| Dec 31, 2024 | 1.18 Bn |
| Sep 30, 2024 | 1.14 Bn |
| Jun 30, 2024 | 1.04 Bn |
| Mar 31, 2024 | 880.89 Mn |
| Dec 31, 2023 | 1.01 Bn |
| Sep 30, 2023 | 919.03 Mn |
| Jun 30, 2023 | 954.61 Mn |
| Mar 31, 2023 | 808.67 Mn |
| Dec 31, 2022 | 926.70 Mn |
| Sep 30, 2022 | 823.30 Mn |
| Jun 30, 2022 | 911.40 Mn |
| Mar 31, 2022 | 733.24 Mn |
| Dec 31, 2021 | 862.85 Mn |
| Sep 30, 2021 | 812.99 Mn |
| Jun 30, 2021 | 705.71 Mn |